Recalls
Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.
Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means deaths or serious injuries are reported, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.
The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.
Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.
Minimum severity
Aurobindo Pharma USA Inc. is recalling Valsartan and Hydrochlorothiazide tablets because FDA testing found the impurity NDEA above acceptable levels.
Sun Pharmaceutical Industries is recalling Vecuronium Bromide for Injection because glass particles were detected in the product.
Lupin Pharmaceuticals is recalling Ceftriaxone for Injection USP due to the presence of grey rubber particulate matter in the vials.
Baxter Healthcare is recalling 29,370 bags of Dianeal Low Calcium peritoneal dialysis solution because confirmed customer complaints identified leaks in the tubing, compromising sterility.
Sun Pharmaceutical Industries is recalling Vecuronium Bromide for Injection because glass particles were detected in the product.
Lupin Pharmaceuticals is recalling Ceftriaxone for Injection USP, 500 mg, due to the presence of grey rubber particulate matter from stoppers.
Heritage Pharmaceuticals is recalling Cidofovir Injection vials due to complaints about dried powder on the outside of the bottles, which raises concerns about sterility.
Lupin Pharmaceuticals is recalling Ceftriaxone for Injection USP, 250 mg, due to the presence of grey rubber particulate matter from stoppers in reconstituted vials.
Lupin Pharmaceuticals is recalling Ceftriaxone for Injection USP vials because grey rubber flecks were found in the reconstituted product.
Northwest Compounding Pharmacy is recalling HCG liquid vials because they may lack sterility assurance. The product was distributed in Oregon to medical facilities and patients.
Northwest Compounding Pharmacy is recalling 60 ml bottles of Glutathione liquid, 100mg/ml, due to a lack of sterility assurance. The product was distributed in Oregon to medical facilities and patients.
Northwest Compounding Pharmacy is recalling Hydroxyprogesterone liquid, 250mg/ml, due to a lack of sterility assurance. The product was distributed in Oregon to medical facilities and patients.
Northwest Compounding Pharmacy is recalling prescription Glutathione liquid in Oregon due to a lack of sterility assurance.
Northwest Compounding Pharmacy is recalling MIC B vitamin liquid due to a lack of sterility assurance. The product was distributed in Oregon to medical facilities and patients.
Northwest Compounding Pharmacy is recalling compounded Cyclosporin liquid 0.2% due to a lack of sterility assurance. The product was distributed in Oregon to medical facilities and patients.
Northwest Compounding Pharmacy is recalling Methocarbamol liquid 100mg/ml glass vials due to a lack of sterility assurance. The product was distributed in Oregon to medical facilities and patients.
Northwest Compounding Pharmacy is recalling Lidocaine/Epinephrine liquid 1%/1:1000 in 50 ml glass vials due to a lack of sterility assurance. The product was distributed in Oregon to medical facilities and patients.
Northwest Compounding Pharmacy is recalling specific lots of compounded Cyclosporin liquid 2% for dry eye due to a lack of sterility assurance. The product was distributed in Oregon.
Northwest Compounding Pharmacy is recalling Lidocaine gel 1% in Oregon due to a lack of sterility assurance. The product was distributed to medical facilities and patients.
Northwest Compounding Pharmacy is recalling compounded cyclosporin liquid 1% due to a lack of sterility assurance. The product was distributed in Oregon to medical facilities and patients.
Northwest Compounding Pharmacy is recalling Cyclosporin liquid 0.05% due to a lack of sterility assurance. The product was distributed in Oregon to medical facilities and patients.
Northwest Compounding Pharmacy is recalling Lidocaine gel 2% due to a lack of sterility assurance. The product was distributed in Oregon to medical facilities and patients.
Northwest Compounding Pharmacy is recalling Epinephrine liquid 1:1000 in 50 ml glass vials due to a lack of sterility assurance. The product was distributed in Oregon to medical facilities and patients.
Northwest Compounding Pharmacy is recalling compounded Cyclosporin liquid 0.5% in plastic dropper bottles due to a lack of sterility assurance. The product was distributed in Oregon to medical facilities, a physician's office, and patients.
Northwest Compounding Pharmacy is recalling Testosteron Cypionate liquid 200mg/ml because of a lack of sterility assurance. The product was distributed in Oregon to medical facilities, a physician's office, and patients.